Nudge Spotlight Account Briefs
ED471901-4303-4CC6-BB60-61574FD72DB7 Created with sketchtool.
Valeant Pharmaceuticals Account Brief
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical and medical device company that develops, manufactures and markets a broad range of prescription and non-prescription pharmaceutical products that make a meaningful difference in patients’ lives throughout more than 100 countries. Valeant’s primary focus is in the areas of dermatology and eye health. Valeant has an established portfolio of durable products and our strategy is to focus the business on core geographies and therapeutic areas that offer high-growth opportunities. Another critical element of our strategy is business development. We have completed numerous transactions over the past few years, including the acquisition of international eye health organization Bausch + Lomb in 2013, to expand our portfolio and our geographic footprint. We will continue to pursue value-added business development opportunities as they arise. Valeant’s strategic markets are primarily in th
Valeant Pharmaceuticals Recent News Mentions
See 3 more news mentions
Executives and decision-makers at Valeant Pharmaceuticals’s relationship intelligence platform can help you find the right executive to reach out to at Valeant Pharmaceuticals, such as Peter Seidenberg, Information Technology Manager, Business Process Owner, or Mohamed Ibrahim, Finance Director - Me. Then get in touch and start a conversation.
Peter Seidenberg Information Technology Manager, Business Process Owner
Get in touch
Mohamed Ibrahim Finance Director - Me
Get in touch
Brian Stolz Strategy Manager-Artificial Lift
Get in touch
Jacques Dessureault President And General Manager
Get in touch
Tage Ramakrishna Chief Medical Officer
Get in touch
Geoff Glass CIO
Get in touch
Eric Abramson Senior Vice President & General Manager, Dermatology & Immunology Franchise
Get in touch
William Humphries Executive Vice President, Group Company Chairman Dermatology
Get in touch
Kelly Webber Senior Vice President Human Resources
Get in touch
Scott Hirsch Senior Vice President, Business Strategy
Get in touch
See 5 more decision makers
Connectors at Valeant Pharmaceuticals
Executives can be difficult to reach, but every company has connectors who bring together people and ideas. At Valeant Pharmaceuticals, people like Joseph Papa are likely connectors.
Joseph Papa Chief Executive Officer & Chairman Of The Board
Ask for intro
See who in your network has relationships at Valeant Pharmaceuticals With you can uncover which contacts at a company your network is most strongly connected to. If you find a strong relationship, ask for an introduction!
Topics frequently mentioned alongside Valeant Pharmaceuticals
When Valeant Pharmaceuticals is mentioned in the news, often sees topics like Growth, and Retail. If your conversation focuses on these topics, you’ll probably get Valeant Pharmaceuticals’s attention.
Companies frequently mentioned alongside Valeant Pharmaceuticals
When Valeant Pharmaceuticals is mentioned in the news, companies such as Allergan PLC, Cardinal Health, and Mylan are often also mentioned. These companies can serve as customer examples.
Valeant Pharmaceuticals employees mentioned in the news
Employees who are often in the news are usually open to starting conversations or exploring ideas.'s sales AI saw Joseph Papa from Valeant Pharmaceuticals recently mentioned in the news.
Executives Get in touch with decision-makers at Valeant Pharmaceuticals. Sign up for Nudge Premium to:
See who in your network can offer a warm intro
Get insights on the company's key decision-makers
Start 30-day free trial now
Connectors Ask connectors at Valeant Pharmaceuticals for intros to execs. Sign up for Nudge Premium to:
See who in your network can offer a warm intro to connectors
Leverage your network to find pathways into new companies
Start 30-day free trial now
Recent News Don't waste time researching your targets. Sign up for Nudge Premium to:
Get notified when your target accounts are mentioned in the news
Get insights on target companies right within your inbox as you write emails
Start 30-day free trial now